open access

Vol 13, No 4 (2016)
Review paper
Get Citation

Some methodological approaches to the complex diagnosis of mental and behavioral disorders in patients with chronic pain

Nataliya Ryshkovska, Krystyna Bohuta, Anastasiya Kruta
Psychiatria 2016;13(4):198-202.

open access

Vol 13, No 4 (2016)
Prace poglądowe - nadesłane

Abstract

The article describes diagnostic aspect of some clinical and psychosocial characteristics of patients with chronic pain syndrome from the viewpoint of the biopsychosocial model of pain Integrative approach for complex clinical picture: the actual chronic pain, affective and cognitive responses to pain, pain behaviour was emphasized in the paper.

Abstract

The article describes diagnostic aspect of some clinical and psychosocial characteristics of patients with chronic pain syndrome from the viewpoint of the biopsychosocial model of pain Integrative approach for complex clinical picture: the actual chronic pain, affective and cognitive responses to pain, pain behaviour was emphasized in the paper.

Get Citation

Keywords

biopsychosocial model of pain, chronic pain, diagnosis, testing, pain behaviour

About this article
Title

Some methodological approaches to the complex diagnosis of mental and behavioral disorders in patients with chronic pain

Journal

Psychiatria (Psychiatry)

Issue

Vol 13, No 4 (2016)

Article type

Review paper

Pages

198-202

Bibliographic record

Psychiatria 2016;13(4):198-202.

Keywords

biopsychosocial model of pain
chronic pain
diagnosis
testing
pain behaviour

Authors

Nataliya Ryshkovska
Krystyna Bohuta
Anastasiya Kruta

References (30)
  1. Gatchel RJ, Peng YBo, Peters ML, et al. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007; 133(4): 581–624.
  2. Голубев ВЛ, Данилов АБ. Психологические установки пациента и пережива-ние боли. Cпециальный выпуск «Болевой синдром». РМЖ. 2009: 11–14.
  3. Чабан ОС, Хаустова ОО. Терапія хронічного алгічного синдрому у пацієнтів з непсихотичними депресивними розладами і коморбідною соматичною патологією. Український вісник психоневрології 2010; 18. 2010; 18: 67–72.
  4. Эмптедж НП, Эмптедж НП, Стурм РС, et al. Депрессия и коморбидная боль как предикторы функциональных ограничений, потери работы, страховки и удорожания стоимости медицинской помощи. Социальная и клиническая психиа-трия . 2011; 21(1): 35–36.
  5. Arnold LM, Hudson JI, Keck PE, et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006; 67(8): 1219–1225.
  6. Chapman S. Managing pain in the older person. Nurs Stand. 2010; 25(11): 35–39.
  7. Cook KF, Keefe F, Jensen MP, et al. Development and validation of a new self-report measure of pain behaviors. Pain. 2013; 154(12): 2867–2876.
  8. Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathology. 2000; 33(6): 307–309.
  9. Deyo RA, Mirza SK, Turner JA, et al. Overtreating chronic back pain: time to back off? J Am Board Fam Med. 2009; 22(1): 62–68.
  10. Frampton CL, Hughes-Webb P. The measurement of pain. Clin Oncol (R Coll Radiol). 2011; 23(6): 381–386.
  11. Geisser ME. The influence of coping styles and personality traits on pain. . In: Dworkin RH, Breitbart W. ed. Psychosocial aspects of pain: a handbook for health care providers, progress in pain research and management (Vol. 27). IASP Press, Seattle 2004: 521–546.
  12. Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005; 52(5): 1577–1584.
  13. Green L, McGhie J. Assessment of acute and chronic pain. Anaesthesia & Intensive Care Medicine. 2013; 14(1): 488–490.
  14. Larson SL, Clark MR, Eaton WW. Depressive disorder as a long-term antecedent risk factor for incident back pain: a 13-year follow-up study from the Baltimore Epidemiological Catchment Area sample. Psychol Med. 2004; 34(2): 211–219.
  15. Lazarus RS, Folkman S. Stress Appraisal, and Coping. , New York 1984: 456.
  16. Li JX. The application of conditioning paradigms in the measurement of pain. Eur J Pharmacol. 2013; 716(1-3): 158–168.
  17. Manchikanti L, Fellows B, Pampati V, et al. Comparison of psychological status of chronic pain patients and the general population. Pain Physician. 2002; 5(1): 40–48.
  18. McGuire DB. Comprehensive and multidimensional assessment and measurement of pain. J Pain Symptom Manage. 1992; 7(5): 312–319.
  19. Misailidou V, Malliou P, Beneka A, et al. Assessment of patients with neck pain: a review of definitions, selection criteria, and measurement tools. J Chiropr Med. 2010; 9(2): 49–59.
  20. Mystakidou K, Tsilika E, Parpa E, et al. Exploring the relationships between depression, hopelessness, cognitive status, pain, and spirituality in patients with advanced cancer. Arch Psychiatr Nurs. 2007; 21(3): 150–161.
  21. Mystakidou K, Tsilika E, Parpa E, et al. Psychological distress of patients with advanced cancer: influence and contribution of pain severity and pain interference. Cancer Nurs. 2006; 29(5): 400–405.
  22. Picavet HS, Vlaeyen JWS, Schouten JS. Pain catastrophizing and kinesiophobia: predictors of chronic low back pain. Am J Epidemiol. 2002; 156(11): 1028–1034.
  23. Cardenas DD, Nieshoff EC, Suda K, et al. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury. Neurology. 2013; 80(6): 533–539.
  24. Tauben D, Theodore B. Measurement-Based Stepped Care Approach to Interdisciplinary Chronic Pain Management. Practical Management of Pain. 2013: 37–46.
  25. Siddall PJ, Cousins MJ, Otte A, et al. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology. 2006; 67(10): 1792–1800.
  26. Attal N. [Pharmacological treatment of neuropathic pain in primary care]. Rev Prat. 2013; 63(6): 795–802.
  27. Ohtori S, Inoue G, Orita S, et al. Efficacy of combination of meloxicam and pregabalin for pain in knee osteoarthritis. Yonsei Med J. 2013; 54(5): 1253–1258.
  28. Blanco Tarrio E, Gálvez Mateos R, Zamorano Bayarri E, et al. Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting. Clin Drug Investig. 2013; 33(9): 633–645.
  29. Martinotti G, Lupi M, Sarchione F, et al. The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview. Curr Pharm Des. 2013; 19(35): 6367–6374.
  30. Siwek M. Leki przeciwdepresyjne w terapii bólu. W: Dudek D. (red.) Ból i depresja. Termedia, Poznań 2011: 141–166.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl